Teva announces FDA approval of AirDuo Digihaler (fluticasone propionate 113 mcg and salmeterol 14 mcg) inhalation powder

15 July 2019 - The first digital maintenance asthma inhaler therapy with integrated sensors joins Teva’s digital rescue inhaler therapy to ...

Read more →

How Australia could almost eradicate H.I.V. transmissions

10 July 2019 - It took universal health care, political will and a health campaign designed to terrify the public, ...

Read more →

ViiV Healthcare announces start of first-ever study to identify and evaluate approaches to implementing its once-monthly injectable HIV treatment in clinical practice

9 July 2019 - The long-acting injectable regimen has been granted priority review status by the FDA, with a target approval ...

Read more →

Cystic fibrosis scandal: Drugs boss tells boy, 9, he wants NHS deal to save lives

8 July 2019 - The millionaire boss of a US drugs firm has penned a personal letter to a boy with ...

Read more →

ViiV Healthcare receives EU marketing authorisation for Dovato (dolutegravir/lamivudine), a new once-daily, single-pill, two-drug regimen for the treatment of HIV-1 infection

3 July 2019 - Authorisation based on GEMINI pivotal trials in which Dovato achieved non-inferior efficacy compared to a dolutegravir-based, three-drug ...

Read more →

FDA issues complete response letter for Ryaltris (olopatadine hydrochloride and mometasone furoate)

22 June 2019 - We would like to inform you that the U.S. FDA has issued a complete response letter ...

Read more →

FDA expands approval of treatment for cystic fibrosis to include patients ages 6 and older

21 June 2019 - The U.S. FDA today expanded the indication for Symdeko (a combination of tezacaftor/ivacaftor) tablets for treatment of ...

Read more →

Buyers’ Club wants government support on Orkambi imports

17 June 2019 - Proposes three point plan to work round impasse. ...

Read more →

Theresa May tells drugs firm to make a deal and end misery

13 June 2019 - Prime Minister Theresa May told MPs that the deal being proposed... a £108million-a-year contract... was fair and ...

Read more →

Free daily HIV prevention pills will soon be available to private insurance holders

11 June 2019 - Patients with private health insurance will soon be able to get HIV prevention medication at no cost. ...

Read more →

MPs to debate cystic fibrosis drug Orkambi in Parliament

10 June 2019 - A debate is due to take place in Westminster about a drug for people living with ...

Read more →

Orkambi row: government now considering Crown Use licensing

11 June 2019 - MPs call for radical solutions as deadlock remains. ...

Read more →

Families create buyers club for cut-price cystic fibrosis drug

5 June 2019 - Stalemate in NHS talks over Orkambi leads parents to buy generic version from Argentina. ...

Read more →

U.S. FDA accepts new drug application for triple combination tablet for adults with type 2 diabetes

4 June 2019 - The U.S. FDA has accepted the new drug application for the investigational fixed-dose combination tablet of empagliflozin, ...

Read more →

FDA approves new treatment for hospital-acquired and ventilator-associated bacterial pneumonia

3 June 2019 - The U.S. FDA today approved a new indication for the previously FDA approved drug, Zerbaxa (ceftolozane and ...

Read more →